Problem: Nonadherence to medications for patients diagnosed with schizophrenia can be the greatest predictor of symptom relapse and hospitalization, adversely impacting the disease trajectory and patient outcomes. Discuss prescriptive advantages and disadvantages of prescribing of long-acting injectables (LOA), highlighting how this dosage form could act as both a facilitator and a barrier to medication adherence for this patient population.